Home › Companies › ROCKET PHARMACEUTICALS INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and ROCKET PHARMACEUTICALS INC.’s Form 8-K, filed June 18, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 18, 2025: 12 items on ROCKET PHARMACEUTICALS INC.’s Form 8-K, filed June 18, 2025: 2 approved · 10 passed (calculated).
Significant dissent: 1 director (30.1% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore ROCKET PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are ROCKET PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 18, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Roderick Wong, M.D. | 78,146,900 | -- | -- | 991,948 | 12,227,613 | 99% | Passed (calculated) | — |
| Elect Director: Elisabeth Björk, M.D., Ph.D. | 76,976,311 | -- | -- | 2,162,537 | 12,227,613 | 97% | Passed (calculated) | — |
| Elect Director: Carsten Boess | 78,224,283 | -- | -- | 914,565 | 12,227,613 | 99% | Passed (calculated) | — |
| Elect Director: Mikael Dolsten, M.D., Ph.D. | 76,051,973 | -- | -- | 3,086,875 | 12,227,613 | 96% | Passed (calculated) | — |
| Elect Director: Pedro Granadillo | 73,571,818 | -- | -- | 5,567,030 | 12,227,613 | 93% | Passed (calculated) | — |
| Elect Director: Gotham Makker, M.D. | 73,798,301 | -- | -- | 5,340,547 | 12,227,613 | 93% | Passed (calculated) | — |
| Elect Director: Fady Malik, M.D., Ph.D. | 78,249,290 | -- | -- | 889,558 | 12,227,613 | 99% | Passed (calculated) | — |
| Elect Director: Piratip Pratumsuwan | 78,595,512 | -- | -- | 543,336 | 12,227,613 | 99.3% | Passed (calculated) | — |
| Elect Director: Gaurav Shah, M.D. | 78,411,712 | -- | -- | 727,136 | 12,227,613 | 99.1% | Passed (calculated) | — |
| Elect Director: David P. Southwell | 55,352,568 | -- | -- | 23,786,280 | 12,227,613 | 70% | Passed (calculated) | — |
| 2. Ratification of Appointment of Independent Registered Accounting Firm | 90,696,301 | 141,826 | 528,334 | -- | -- | 99.8% | Approved | — |
| 3. Non-Binding Advisory Vote on the Compensation of the Company's Named Executive Officers | 77,186,221 | 1,437,605 | 515,022 | -- | 12,227,613 | 98% | Approved | — |
Source: ROCKET PHARMACEUTICALS INC., Form 8-K, filed with the SEC on June 18, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
220 asset managers disclosed a vote on at least one ROCKET PHARMACEUTICALS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
70% Majority: yes · of votes cast
Prior year: 99.6% for (June 13, 2024 meeting) ▼ 29.6 pts
Description as filed by funds: Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: David P. Southwell
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: David P. Southwell”): 55,352,568 for, 23,786,280 withheld, per its Form 8-K filed June 18, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 70% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 63 asset managers below reported 17,043,543 for, 9,698,261 withheld, 0 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,905,547 | 0 | 0 | 654 | For |
| BlackRock | 0 | 0 | 0 | 2,621,298 | Withhold |
| State Street | 5,334 | 0 | 0 | 1,915,512 | Withhold |
| Fidelity | 1,785,104 | 0 | 0 | 34,462 | For |
| Federated Hermes | 1,363,556 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 0 | 0 | 0 | 1,232,835 | Withhold |
| T. Rowe Price | 1,186,672 | 0 | 0 | 0 | For |
| Putnam | 0 | 0 | 0 | 1,015,789 | Withhold |
| MUTUAL FUND SERIES TRUST | 770,691 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 686,480 | Withhold |
| TIAA | 0 | 0 | 0 | 392,835 | Withhold |
| Hartford | 343,230 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 0 | 322,438 | Withhold |
| Equitable | 16,956 | 0 | 0 | 194,884 | Mixed |
| Goldman Sachs | 0 | 0 | 0 | 194,102 | Withhold |
| Harbor Funds II | 182,482 | 0 | 0 | 0 | For |
| Global X | 149,626 | 0 | 0 | 0 | For |
| John Hancock | 118,455 | 0 | 0 | 25,661 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 131,134 | Withhold |
| Prudential/PGIM | 0 | 0 | 0 | 119,188 | Withhold |
| Mercer Funds | 0 | 0 | 0 | 110,161 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 92,025 | Withhold |
| Morgan Stanley | 0 | 0 | 0 | 76,420 | Withhold |
| MassMutual | 59,239 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 58,701 | Withhold |
Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 99.2% for (June 13, 2024 meeting) ▼ 0.4 pts
Description as filed by funds: Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Carsten Boess
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Carsten Boess”): 78,224,283 for, 914,565 withheld, per its Form 8-K filed June 18, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 63 asset managers below reported 26,741,661 for, 143 withheld, 0 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,906,201 | 0 | 0 | 0 | For |
| BlackRock | 2,621,298 | 0 | 0 | 0 | For |
| State Street | 1,920,846 | 0 | 0 | 0 | For |
| Fidelity | 1,819,566 | 0 | 0 | 0 | For |
| Federated Hermes | 1,363,556 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,232,835 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,186,672 | 0 | 0 | 0 | For |
| Putnam | 1,015,789 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 770,691 | 0 | 0 | 0 | For |
| Charles Schwab | 686,480 | 0 | 0 | 0 | For |
| TIAA | 392,835 | 0 | 0 | 0 | For |
| Hartford | 343,230 | 0 | 0 | 0 | For |
| Invesco | 322,438 | 0 | 0 | 0 | For |
| Equitable | 211,840 | 0 | 0 | 0 | For |
| Goldman Sachs | 194,102 | 0 | 0 | 0 | For |
| Harbor Funds II | 182,482 | 0 | 0 | 0 | For |
| Global X | 149,626 | 0 | 0 | 0 | For |
| John Hancock | 144,116 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 131,134 | 0 | 0 | 0 | For |
| Prudential/PGIM | 119,188 | 0 | 0 | 0 | For |
| Mercer Funds | 110,161 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 92,025 | 0 | 0 | 0 | For |
| Morgan Stanley | 76,420 | 0 | 0 | 0 | For |
| MassMutual | 59,239 | 0 | 0 | 0 | For |
| Lincoln Financial | 58,701 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 99.7% for (June 13, 2024 meeting) ▼ 0.8 pts
Description as filed by funds: Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Fady Malik, M.D., Ph.D.
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Fady Malik, M.D., Ph.D.”): 78,249,290 for, 889,558 withheld, per its Form 8-K filed June 18, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 63 asset managers below reported 26,741,804 for, 0 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,906,201 | 0 | 0 | 0 | For |
| BlackRock | 2,621,298 | 0 | 0 | 0 | For |
| State Street | 1,920,846 | 0 | 0 | 0 | For |
| Fidelity | 1,819,566 | 0 | 0 | 0 | For |
| Federated Hermes | 1,363,556 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,232,835 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,186,672 | 0 | 0 | 0 | For |
| Putnam | 1,015,789 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 770,691 | 0 | 0 | 0 | For |
| Charles Schwab | 686,480 | 0 | 0 | 0 | For |
| TIAA | 392,835 | 0 | 0 | 0 | For |
| Hartford | 343,230 | 0 | 0 | 0 | For |
| Invesco | 322,438 | 0 | 0 | 0 | For |
| Equitable | 211,840 | 0 | 0 | 0 | For |
| Goldman Sachs | 194,102 | 0 | 0 | 0 | For |
| Harbor Funds II | 182,482 | 0 | 0 | 0 | For |
| Global X | 149,626 | 0 | 0 | 0 | For |
| John Hancock | 144,116 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 131,134 | 0 | 0 | 0 | For |
| Prudential/PGIM | 119,188 | 0 | 0 | 0 | For |
| Mercer Funds | 110,161 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 92,025 | 0 | 0 | 0 | For |
| Morgan Stanley | 76,420 | 0 | 0 | 0 | For |
| MassMutual | 59,239 | 0 | 0 | 0 | For |
| Lincoln Financial | 58,701 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Prior year: 99.4% for (June 13, 2024 meeting) ▼ 6.2 pts
Description as filed by funds: Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Gotham Makker, M.D.
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Gotham Makker, M.D.”): 73,798,301 for, 5,340,547 withheld, per its Form 8-K filed June 18, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 63 asset managers below reported 24,513,901 for, 2,227,903 withheld, 0 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,905,547 | 0 | 0 | 654 | For |
| BlackRock | 2,621,298 | 0 | 0 | 0 | For |
| State Street | 1,920,846 | 0 | 0 | 0 | For |
| Fidelity | 1,819,566 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 0 | 0 | 1,363,556 | Withhold |
| HARBOR FUNDS | 1,232,835 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,186,672 | 0 | 0 | 0 | For |
| Putnam | 1,015,789 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 770,691 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 686,480 | Withhold |
| TIAA | 392,835 | 0 | 0 | 0 | For |
| Hartford | 343,230 | 0 | 0 | 0 | For |
| Invesco | 322,438 | 0 | 0 | 0 | For |
| Equitable | 211,840 | 0 | 0 | 0 | For |
| Goldman Sachs | 194,102 | 0 | 0 | 0 | For |
| Harbor Funds II | 182,482 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 149,626 | Withhold |
| John Hancock | 144,116 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 131,134 | 0 | 0 | 0 | For |
| Prudential/PGIM | 119,188 | 0 | 0 | 0 | For |
| Mercer Funds | 110,161 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 92,025 | 0 | 0 | 0 | For |
| Morgan Stanley | 76,420 | 0 | 0 | 0 | For |
| MassMutual | 59,239 | 0 | 0 | 0 | For |
| Lincoln Financial | 58,701 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Prior year: 99.5% for (June 13, 2024 meeting) ▼ 0.4 pts
Description as filed by funds: Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Gaurav Shah, M.D.
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Gaurav Shah, M.D.”): 78,411,712 for, 727,136 withheld, per its Form 8-K filed June 18, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 63 asset managers below reported 26,741,804 for, 0 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,906,201 | 0 | 0 | 0 | For |
| BlackRock | 2,621,298 | 0 | 0 | 0 | For |
| State Street | 1,920,846 | 0 | 0 | 0 | For |
| Fidelity | 1,819,566 | 0 | 0 | 0 | For |
| Federated Hermes | 1,363,556 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,232,835 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,186,672 | 0 | 0 | 0 | For |
| Putnam | 1,015,789 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 770,691 | 0 | 0 | 0 | For |
| Charles Schwab | 686,480 | 0 | 0 | 0 | For |
| TIAA | 392,835 | 0 | 0 | 0 | For |
| Hartford | 343,230 | 0 | 0 | 0 | For |
| Invesco | 322,438 | 0 | 0 | 0 | For |
| Equitable | 211,840 | 0 | 0 | 0 | For |
| Goldman Sachs | 194,102 | 0 | 0 | 0 | For |
| Harbor Funds II | 182,482 | 0 | 0 | 0 | For |
| Global X | 149,626 | 0 | 0 | 0 | For |
| John Hancock | 144,116 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 131,134 | 0 | 0 | 0 | For |
| Prudential/PGIM | 119,188 | 0 | 0 | 0 | For |
| Mercer Funds | 110,161 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 92,025 | 0 | 0 | 0 | For |
| Morgan Stanley | 76,420 | 0 | 0 | 0 | For |
| MassMutual | 59,239 | 0 | 0 | 0 | For |
| Lincoln Financial | 58,701 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Mikael Dolsten, M.D., Ph.D.
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Mikael Dolsten, M.D., Ph.D.”): 76,051,973 for, 3,086,875 withheld, per its Form 8-K filed June 18, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 63 asset managers below reported 24,362,459 for, 2,379,345 withheld, 0 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,906,201 | 0 | 0 | 0 | For |
| BlackRock | 2,621,298 | 0 | 0 | 0 | For |
| State Street | 1,920,846 | 0 | 0 | 0 | For |
| Fidelity | 1,819,566 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 0 | 0 | 1,363,556 | Withhold |
| HARBOR FUNDS | 1,232,835 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,186,672 | 0 | 0 | 0 | For |
| Putnam | 0 | 0 | 0 | 1,015,789 | Withhold |
| MUTUAL FUND SERIES TRUST | 770,691 | 0 | 0 | 0 | For |
| Charles Schwab | 686,480 | 0 | 0 | 0 | For |
| TIAA | 392,835 | 0 | 0 | 0 | For |
| Hartford | 343,230 | 0 | 0 | 0 | For |
| Invesco | 322,438 | 0 | 0 | 0 | For |
| Equitable | 211,840 | 0 | 0 | 0 | For |
| Goldman Sachs | 194,102 | 0 | 0 | 0 | For |
| Harbor Funds II | 182,482 | 0 | 0 | 0 | For |
| Global X | 149,626 | 0 | 0 | 0 | For |
| John Hancock | 144,116 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 131,134 | 0 | 0 | 0 | For |
| Prudential/PGIM | 119,188 | 0 | 0 | 0 | For |
| Mercer Funds | 110,161 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 92,025 | 0 | 0 | 0 | For |
| Morgan Stanley | 76,420 | 0 | 0 | 0 | For |
| MassMutual | 59,239 | 0 | 0 | 0 | For |
| Lincoln Financial | 58,701 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Prior year: 71.5% for (June 13, 2024 meeting) ▲ 21.5 pts
Description as filed by funds: Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Pedro Granadillo
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Pedro Granadillo”): 73,571,818 for, 5,567,030 withheld, per its Form 8-K filed June 18, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 63 asset managers below reported 25,878,915 for, 862,889 withheld, 0 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,905,547 | 0 | 0 | 654 | For |
| BlackRock | 2,621,298 | 0 | 0 | 0 | For |
| State Street | 1,920,846 | 0 | 0 | 0 | For |
| Fidelity | 1,819,566 | 0 | 0 | 0 | For |
| Federated Hermes | 1,363,556 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,232,835 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,186,672 | 0 | 0 | 0 | For |
| Putnam | 1,015,789 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 770,691 | 0 | 0 | 0 | For |
| Charles Schwab | 686,480 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 392,835 | Withhold |
| Hartford | 343,230 | 0 | 0 | 0 | For |
| Invesco | 322,438 | 0 | 0 | 0 | For |
| Equitable | 138,080 | 0 | 0 | 73,760 | Mixed |
| Goldman Sachs | 123,500 | 0 | 0 | 70,602 | Mixed |
| Harbor Funds II | 182,482 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 149,626 | Withhold |
| John Hancock | 144,116 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 131,134 | 0 | 0 | 0 | For |
| Prudential/PGIM | 8,070 | 0 | 0 | 111,118 | Mixed |
| Mercer Funds | 110,161 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 92,025 | 0 | 0 | 0 | For |
| Morgan Stanley | 76,420 | 0 | 0 | 0 | For |
| MassMutual | 59,239 | 0 | 0 | 0 | For |
| Lincoln Financial | 58,701 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Description as filed by funds: Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Piratip Pratumsuwan
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Piratip Pratumsuwan”): 78,595,512 for, 543,336 withheld, per its Form 8-K filed June 18, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 63 asset managers below reported 26,741,804 for, 0 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,906,201 | 0 | 0 | 0 | For |
| BlackRock | 2,621,298 | 0 | 0 | 0 | For |
| State Street | 1,920,846 | 0 | 0 | 0 | For |
| Fidelity | 1,819,566 | 0 | 0 | 0 | For |
| Federated Hermes | 1,363,556 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,232,835 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,186,672 | 0 | 0 | 0 | For |
| Putnam | 1,015,789 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 770,691 | 0 | 0 | 0 | For |
| Charles Schwab | 686,480 | 0 | 0 | 0 | For |
| TIAA | 392,835 | 0 | 0 | 0 | For |
| Hartford | 343,230 | 0 | 0 | 0 | For |
| Invesco | 322,438 | 0 | 0 | 0 | For |
| Equitable | 211,840 | 0 | 0 | 0 | For |
| Goldman Sachs | 194,102 | 0 | 0 | 0 | For |
| Harbor Funds II | 182,482 | 0 | 0 | 0 | For |
| Global X | 149,626 | 0 | 0 | 0 | For |
| John Hancock | 144,116 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 131,134 | 0 | 0 | 0 | For |
| Prudential/PGIM | 119,188 | 0 | 0 | 0 | For |
| Mercer Funds | 110,161 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 92,025 | 0 | 0 | 0 | For |
| Morgan Stanley | 76,420 | 0 | 0 | 0 | For |
| MassMutual | 59,239 | 0 | 0 | 0 | For |
| Lincoln Financial | 58,701 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 99.1% for (June 13, 2024 meeting) ▼ 0.3 pts
Description as filed by funds: Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Roderick Wong, M.D.
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Roderick Wong, M.D.”): 78,146,900 for, 991,948 withheld, per its Form 8-K filed June 18, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 63 asset managers below reported 26,713,960 for, 27,844 withheld, 0 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,905,547 | 0 | 0 | 654 | For |
| BlackRock | 2,621,298 | 0 | 0 | 0 | For |
| State Street | 1,920,810 | 0 | 0 | 36 | For |
| Fidelity | 1,819,566 | 0 | 0 | 0 | For |
| Federated Hermes | 1,363,556 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,232,835 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,186,672 | 0 | 0 | 0 | For |
| Putnam | 1,015,789 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 770,691 | 0 | 0 | 0 | For |
| Charles Schwab | 686,480 | 0 | 0 | 0 | For |
| TIAA | 392,835 | 0 | 0 | 0 | For |
| Hartford | 343,230 | 0 | 0 | 0 | For |
| Invesco | 322,438 | 0 | 0 | 0 | For |
| Equitable | 211,840 | 0 | 0 | 0 | For |
| Goldman Sachs | 194,102 | 0 | 0 | 0 | For |
| Harbor Funds II | 182,482 | 0 | 0 | 0 | For |
| Global X | 149,626 | 0 | 0 | 0 | For |
| John Hancock | 144,116 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 131,134 | 0 | 0 | 0 | For |
| Prudential/PGIM | 119,188 | 0 | 0 | 0 | For |
| Mercer Funds | 110,161 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 92,025 | 0 | 0 | 0 | For |
| Morgan Stanley | 76,420 | 0 | 0 | 0 | For |
| MassMutual | 59,239 | 0 | 0 | 0 | For |
| Lincoln Financial | 58,701 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Prior year: 94.0% for (June 13, 2024 meeting) ▲ 3.3 pts
Description as filed by funds: Election of the ten directors named in the proxy statement to hold office until the annual meeting of stockholders in 2026, or until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Elisabeth Bjork, M.D., Ph.D.
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Elisabeth Björk, M.D., Ph.D.”): 76,976,311 for, 2,162,537 withheld, per its Form 8-K filed June 18, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 24,930,967 for, 1,035,146 withheld, 0 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,906,201 | 0 | 0 | 0 | For |
| BlackRock | 2,621,298 | 0 | 0 | 0 | For |
| State Street | 1,920,846 | 0 | 0 | 0 | For |
| Fidelity | 1,819,566 | 0 | 0 | 0 | For |
| Federated Hermes | 1,363,556 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,232,835 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,186,672 | 0 | 0 | 0 | For |
| Putnam | 0 | 0 | 0 | 1,015,789 | Withhold |
| Charles Schwab | 686,480 | 0 | 0 | 0 | For |
| TIAA | 392,835 | 0 | 0 | 0 | For |
| Hartford | 343,230 | 0 | 0 | 0 | For |
| Invesco | 322,438 | 0 | 0 | 0 | For |
| Equitable | 211,840 | 0 | 0 | 0 | For |
| Goldman Sachs | 194,102 | 0 | 0 | 0 | For |
| Harbor Funds II | 182,482 | 0 | 0 | 0 | For |
| Global X | 149,626 | 0 | 0 | 0 | For |
| John Hancock | 144,116 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 131,134 | 0 | 0 | 0 | For |
| Prudential/PGIM | 119,188 | 0 | 0 | 0 | For |
| Mercer Funds | 110,161 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 92,025 | 0 | 0 | 0 | For |
| Morgan Stanley | 76,420 | 0 | 0 | 0 | For |
| MassMutual | 59,239 | 0 | 0 | 0 | For |
| Lincoln Financial | 58,701 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 58,000 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).
Combines 12 wordings of this item as funds reported it.
98% Approved · of votes cast
Prior year: 98.4% for (June 13, 2024 meeting) ▼ 0.2 pts
Description as filed by funds: Consider and act upon a non-binding, advisory vote on the compensation of our named executive officers;
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“3. Non-Binding Advisory Vote on the Compensation of the Company's Named Executive Officers”): 77,186,221 for, 1,437,605 against — passed, per its Form 8-K filed June 18, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Three - Non-Binding Advisory Vote on the Compensation of the Company's Named Executive Officers The Company's stockholders approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2025 Proxy Statement pursuant to Section 14…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,905,547 | 654 | 0 | 0 | For |
| BlackRock | 2,621,298 | 0 | 0 | 0 | For |
| State Street | 1,920,846 | 0 | 0 | 0 | For |
| Fidelity | 1,819,566 | 0 | 0 | 0 | For |
| Federated Hermes | 1,363,556 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,232,835 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,186,672 | 0 | 0 | 0 | For |
| Putnam | 1,015,789 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 770,691 | 0 | 0 | 0 | For |
| Charles Schwab | 686,480 | 0 | 0 | 0 | For |
| TIAA | 392,835 | 0 | 0 | 0 | For |
| Hartford | 343,230 | 0 | 0 | 0 | For |
| Invesco | 322,438 | 0 | 0 | 0 | For |
| Equitable | 211,840 | 0 | 0 | 0 | For |
| Goldman Sachs | 194,102 | 0 | 0 | 0 | For |
| Harbor Funds II | 182,482 | 0 | 0 | 0 | For |
| Global X | 149,626 | 0 | 0 | 0 | For |
| John Hancock | 144,116 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 131,134 | 0 | 0 | 0 | For |
| Prudential/PGIM | 119,188 | 0 | 0 | 0 | For |
| Mercer Funds | 110,161 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 92,025 | 0 | 0 | 0 | For |
| Morgan Stanley | 76,420 | 0 | 0 | 0 | For |
| MassMutual | 59,239 | 0 | 0 | 0 | For |
| Lincoln Financial | 58,701 | 0 | 0 | 0 | For |
Fund voting reports, all 62 managers: 26,741,007 for, 797 against, 0 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 16,734,217 | 0 | 0 | 0 | For |
| Wellington | 7,225,920 | 0 | 0 | 0 | For |
| MAVERICK CAPITAL LTD | 4,869,725 | 0 | 0 | 0 | For |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,094,387 | 0 | 0 | 0 | For |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3,531,888 | 0 | 0 | 0 | For |
| State Street | 3,343,907 | 0 | 0 | 0 | For |
| BlackRock | 3,175,938 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,007,229 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,621,521 | 0 | 0 | 0 | For |
| Federated Hermes | 1,399,067 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 1,191,568 | 0 | 0 | 0 | For |
| MPM BioImpact LLC | 1,146,660 | 0 | 0 | 0 | For |
| Novo Holdings A/S | 1,100,000 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 1,049,202 | 0 | 0 | 0 | For |
| Putnam | 1,015,789 | 0 | 0 | 0 | For |
| COMERICA BANK | 823,908 | 0 | 0 | 0 | For |
| Charles Schwab | 689,724 | 0 | 0 | 0 | For |
| Nantahala Capital Management, LLC | 629,749 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 591,263 | 0 | 0 | 0 | For |
| JPMorgan | 562,823 | 0 | 0 | 0 | For |
| Citadel | 500,033 | 0 | 0 | 0 | For |
| Northern Trust | 415,683 | 0 | 0 | 0 | For |
| Nuveen | 394,663 | 0 | 0 | 0 | For |
| SYNOVUS FINANCIAL CORP | 389,606 | 0 | 0 | 0 | For |
| M28 Capital Management LP | 385,680 | 0 | 0 | 0 | For |
Institutional-manager reports, all 175 managers: 63,447,548 for, 696,821 against, 201,916 abstained, 77,356 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.8% Approved · of votes cast
Prior year: 99.9% for (June 13, 2024 meeting) unchanged
Description as filed by funds: Ratification of the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025;
ROCKET PHARMACEUTICALS INC.’s own tally for this item (“2. Ratification of Appointment of Independent Registered Accounting Firm”): 90,696,301 for, 141,826 against — passed, per its Form 8-K filed June 18, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Two - Ratification of Appointment of Independent Registered Accounting Firm The Company's stockholders ratified the appointment of EisnerAmper LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2025 by the following votes:”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 63 asset managers below reported 26,741,694 for, 110 against, 0 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,906,201 | 0 | 0 | 0 | For |
| BlackRock | 2,621,298 | 0 | 0 | 0 | For |
| State Street | 1,920,736 | 110 | 0 | 0 | For |
| Fidelity | 1,819,566 | 0 | 0 | 0 | For |
| Federated Hermes | 1,363,556 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,232,835 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,186,672 | 0 | 0 | 0 | For |
| Putnam | 1,015,789 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 770,691 | 0 | 0 | 0 | For |
| Charles Schwab | 686,480 | 0 | 0 | 0 | For |
| TIAA | 392,835 | 0 | 0 | 0 | For |
| Hartford | 343,230 | 0 | 0 | 0 | For |
| Invesco | 322,438 | 0 | 0 | 0 | For |
| Equitable | 211,840 | 0 | 0 | 0 | For |
| Goldman Sachs | 194,102 | 0 | 0 | 0 | For |
| Harbor Funds II | 182,482 | 0 | 0 | 0 | For |
| Global X | 149,626 | 0 | 0 | 0 | For |
| John Hancock | 144,116 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 131,134 | 0 | 0 | 0 | For |
| Prudential/PGIM | 119,188 | 0 | 0 | 0 | For |
| Mercer Funds | 110,161 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 92,025 | 0 | 0 | 0 | For |
| Morgan Stanley | 76,420 | 0 | 0 | 0 | For |
| MassMutual | 59,239 | 0 | 0 | 0 | For |
| Lincoln Financial | 58,701 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 106,753,886 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 10.22% |
| 2 | BlackRock | 2.46% |
| 3 | State Street | 1.80% |
| 4 | Fidelity | 1.70% |
| 5 | Federated Hermes | 1.28% |
| 6 | HARBOR FUNDS | 1.15% |
| 7 | T. Rowe Price | 1.11% |
| 8 | Putnam | 0.95% |
| 9 | MUTUAL FUND SERIES TRUST | 0.72% |
| 10 | Charles Schwab | 0.64% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | RTW INVESTMENTS, LP | 15.68% |
| 2 | Wellington | 6.77% |
| 3 | MAVERICK CAPITAL LTD | 4.56% |
| 4 | SUVRETTA CAPITAL MANAGEMENT, LLC | 3.84% |
| 5 | WESTFIELD CAPITAL MANAGEMENT CO LP | 3.31% |
| 6 | State Street | 3.13% |
| 7 | BlackRock | 2.98% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 1.88% |
| 9 | T. Rowe Price | 1.52% |
| 10 | Federated Hermes | 1.31% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| RTW Investments, LP | 18,188,457 | 17.04% | Proxy statement (DEF 14A), proxy filed April 30, 2025 |
| Wellington Management | 12,626,491 | 11.83% | Form 13F, quarter ended March 31, 2025 |
| BlackRock | 7,274,234 | 6.81% | Form 13F, quarter ended March 31, 2025 |
| Vanguard Group | 6,617,784 | 6.20% | Form 13F, quarter ended March 31, 2025 |
| Maverick Capital, Ltd. | 5,547,175 | 5.20% | Proxy statement (DEF 14A), proxy filed April 30, 2025 |
| State Street | 3,705,461 | 3.47% | Form 13F, quarter ended March 31, 2025 |
| Gaurav Shah, M.D. | 3,209,364 | 3.01% | Proxy statement (DEF 14A), proxy filed April 30, 2025 |
| T. Rowe Price | 3,043,682 | 2.85% | Form 13F, quarter ended March 31, 2025 |
| Morgan Stanley | 2,641,892 | 2.47% | Form 13F, quarter ended March 31, 2025 |
| Geode Capital | 1,994,044 | 1.87% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 106,753,886 shares outstanding, as reported by ROCKET PHARMACEUTICALS INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At ROCKET PHARMACEUTICALS INC.'s shareholder meeting held June 18, 2025, in the 2024-2025 proxy season, 220 asset managers reported votes on at least one of its 12 ballot items in their SEC Form N-PX filings, covering 2,413 separate fund positions. On the most widely held item on that ballot — Consider and act upon a non-binding, advisory vote on the compensation of our named executive… — ROCKET PHARMACEUTICALS INC.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: ROCKET PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 18, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ROCKET PHARMACEUTICALS INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
ROCKET PHARMACEUTICALS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “ROCKET PHARMACEUTICALS (RCKT) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/rocket-pharmaceuticals-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.